Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa
- PMID: 15820714
- DOI: 10.1016/j.biopsych.2005.01.004
Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa
Abstract
Background: Gut-derived peptides, such as peptide YY (PYY) and ghrelin that regulate the initiation and termination of meals, could play a role in the altered eating behavior of patients with bulimia nervosa (BN). Therefore, we aimed to assess plasma PYY and ghrelin responses to a test meal in symptomatic bulimics.
Methods: Ten healthy women and nine women with BN underwent blood sample collections before and after the ingestion of a test meal of 1300 Kcal (with 15% carbohydrates, 10% proteins, and 75% fat) at 12:00 noon. Plasma total PYY, ghrelin, insulin, and glucose were assayed.
Results: As compared with healthy women, bulimics exhibited a significantly blunted increase of circulating PYY (p < .007) and a significantly reduced suppression of plasma ghrelin (p < .0004) after the test meal. No significant differences emerged in food-induced plasma insulin and glucose changes between the two groups. Plasma ghrelin suppression after the meal was significantly correlated with plasma PYY increase.
Conclusions: We replicated our previous findings of an altered ghrelin response to food ingestion in people with BN and showed for the first time a blunted PYY increase after food consumption in these patients. These findings support the occurrence in BN of a profound dysregulation of some peripheral regulatory mechanisms involved in the short-term regulation of feeding behavior that might be involved in the pathophysiology of their binge eating behavior.
Similar articles
-
Altered ghrelin and peptide YY responses to meals in bulimia nervosa.Clin Endocrinol (Oxf). 2005 Jan;62(1):74-8. doi: 10.1111/j.1365-2265.2004.02176.x. Clin Endocrinol (Oxf). 2005. PMID: 15638873
-
Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa.Psychoneuroendocrinology. 2005 Apr;30(3):243-50. doi: 10.1016/j.psyneuen.2004.07.004. Psychoneuroendocrinology. 2005. PMID: 15511598 Clinical Trial.
-
Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.J Physiol Pharmacol. 2007 Mar;58 Suppl 1:13-35. J Physiol Pharmacol. 2007. PMID: 17443025
-
Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants.Am J Physiol Endocrinol Metab. 2010 May;298(5):E909-19. doi: 10.1152/ajpendo.00191.2009. Epub 2010 Feb 23. Am J Physiol Endocrinol Metab. 2010. PMID: 20179246 Review.
-
Neurochemistry of bulimia nervosa.J Clin Psychiatry. 1991 Oct;52 Suppl:21-8. J Clin Psychiatry. 1991. PMID: 1682306 Review.
Cited by
-
Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type.J Clin Psychiatry. 2015 Jan;76(1):19-24. doi: 10.4088/JCP.13m08753. J Clin Psychiatry. 2015. PMID: 25098834 Free PMC article.
-
To eat or not to eat: A role for ghrelin and LEAP2 in eating disorders?Neurosci Appl. 2024 Feb 27;3:104045. doi: 10.1016/j.nsa.2024.104045. eCollection 2024. Neurosci Appl. 2024. PMID: 40656102 Free PMC article. Review.
-
Cannabinoids in eating disorders and obesity.Mol Neurobiol. 2007 Aug;36(1):113-28. doi: 10.1007/s12035-007-0018-x. Epub 2007 Jul 7. Mol Neurobiol. 2007. PMID: 17952656 Review.
-
Emerging Treatments in Eating Disorders.Neurotherapeutics. 2017 Jul;14(3):614-622. doi: 10.1007/s13311-017-0535-x. Neurotherapeutics. 2017. PMID: 28547702 Free PMC article. Review.
-
Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study.Crit Care. 2006 Feb;10(1):R10. doi: 10.1186/cc3957. Crit Care. 2006. PMID: 16420657 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials